OrganiGram Holdings Inc (OGI) reports a 17% increase in net revenue and strategic international expansion, despite facing ...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

Q1 2025 Earnings Call Transcript February 11, 2025 OrganiGram Holdings Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03. Operator: Good morning. My name is ...

Reports Q1 adjusted EBITDA1 C$1.4M vs. C$0.1M in the prior year period. “This is an exciting time for Organigram (OGI) as we kick off Fiscal ...

Asked about international market competition and potential price compression. CEO Goldenberg acknowledged competitive pressures but highlighted the advantages of Moncton's low-cost, high-quality ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Organigram (OGI) to C$3 from C$4.25 and keeps a Buy rating on ...

OrganiGram Holdings' loss widened and revenue growth missed expectations in the first fiscal quarter as the company integrates its acquisition of cannabis producer Motif Labs. The Canadian licensed ...

Organigram Holdings Inc. ( NASDAQ: OGI) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO ...

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram ...

OrganiGram Holdings Inc (TSX:OGI). reported a significant improvement in its financial performance for the third quarter of fiscal year 2024, with a 25% year-over-year increase in net revenue. The ...